News tagged with glimepiride
Added benefit of saxagliptin/metformin combination is not proven
The fixed combination of the drugs saxagliptin and metformin (Komboglyze) has been approved in Germany since November 2011 for the treatment of type 2 diabetes mellitus. In an early benefit assessment pursuant to the "Act ...
Medications
Apr 29, 2013 |
not rated yet |
0
Linagliptin: Once again, no proof of added benefit
Linagliptin (trade name Trajenta) has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes. The assessment of the new dossier according to the German Act on the Reform of the Market ...
Medications
Jan 30, 2013 |
not rated yet |
0
Linagliptin noninferior to glimepiride in type 2 diabetes
(HealthDay) -- A new drug for type 2 diabetes causes significantly less weight gain and may carry lower risks for hypoglycemia (low blood sugar), heart attack and stroke than standard medications, a new study indicates.
Diabetes
Jun 28, 2012 |
not rated yet |
0
